News

GE Research has received a grant from the NIH to develop sensors that can be embedded into mobile devices to detect COVID-19 particles on their surfaces.   

This comes roughly a year after Walgreens pledged to invest $1 billion in equity and convertible debt in VillageMD over a three-year time frame. 

The digital therapeutic is designed to treat children ages 8 to 12 with ADHD, but the two studies announced this week will focus on an adult population.   

Also, startup creates wearable tech to tackle head injuries in sport.

Using a phone’s camera and flash, the MFine Pulse detects light absorption in a user’s fingertip which is then processed via a proprietary algorithm to measure SpO2.

Starting this month, eligible Fitbit Sense users can participate in the study, which will look into how pulse arrival time can be used to measure blood pressure.   

The study found that patients using AliveCor Kardia Mobile required fewer follow-up EGCs and cardiac monitoring than their peers in the control group.

Also: Pre-conception genetic-testing startup Orchid completes seed round, and Canvas Medical scores $17M for its physician practice platform.   

Funding will be used to gain in-human data for startup’s OxiFlow brain haemorrhage solution. 

European digital health coaching company, Liva Healthcare and global biotechnology organisation, Amgen, have announced a partnership to make cardiac rehabilitation accessible to patients following a heart attack.